Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals

Gastroenterology

Volumn 153, Issue 1, 2017, Pages 87-97.e3

  Canfora, Emanuel E ^a,b   van der Beek, Christina M ^a,b   Hermes, Gerben D A ^a,c   Goossens, Gijs H ^a,b   Jocken, Johan W E ^a,b   Holst, Jens J ^d,e   van Eijk, Hans M ^b   Venema, Koen ^a,f   Smidt, Hauke ^a,c   Zoetendal, Erwin G ^a,c   Dejong, Cornelis H C ^a,b,g   Lenaerts, Kaatje ^a,b   Blaak, Ellen E ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d Capital Region   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f Beneficial Microbes Consultancy   (Netherlands)

^g UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Metabolic Control; Microbial Obesity; Prebiotics; Short Chain Fatty Acids

Indexed keywords

GALACTOSE OLIGOSACCHARIDE; GASTROINTESTINAL HORMONE; INCRETIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; MALTODEXTRIN; PLACEBO; PREBIOTIC AGENT; SHORT CHAIN FATTY ACID; ACETIC ACID; ACUTE PHASE PROTEIN; BACTERIAL DNA; CARRIER PROTEIN; CYTOKINE; GALACTOSE; INSULIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN; OLIGOSACCHARIDE;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BIFIDOBACTERIUM; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENERGY EXPENDITURE; FECES MICROFLORA; FEMALE; HORMONE RESPONSE; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; IMPAIRED GLUCOSE TOLERANCE; INDIRECT CALORIMETRY; INFLAMMATION; INSULIN SENSITIVITY; INTERVENTION STUDY; INTESTINE FLORA; LIPID METABOLISM; MALE; METABOLISM; NETHERLANDS; OBESITY; OUTCOME ASSESSMENT; PARALLEL DESIGN; PHYSICAL ACTIVITY; POPULATION ABUNDANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; BLOOD; CHEMISTRY; COMPLICATION; DIETARY SUPPLEMENT; ENERGY METABOLISM; FECES; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; MICROBIOLOGY; MIDDLE AGED;

ACETIC ACID; ACUTE-PHASE PROTEINS; ADIPOSITY; AGED; BIFIDOBACTERIUM; BLOOD GLUCOSE; BODY MASS INDEX; CARRIER PROTEINS; CYTOKINES; DIETARY SUPPLEMENTS; DNA, BACTERIAL; DOUBLE-BLIND METHOD; ENERGY METABOLISM; FECES; FEMALE; GALACTOSE; GASTROINTESTINAL MICROBIOME; HUMANS; INCRETINS; INSULIN; INSULIN RESISTANCE; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OBESITY; OLIGOSACCHARIDES; PREDIABETIC STATE;

EID: 85019695782     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.03.051     Document Type: Article

References (53)

1. Delzenne, N.M., Cani, P.D., Everard, A., et al. Gut microorganisms as promising targets for the management of type 2 diabetes. Diabetologia 58 (2015), 2206–2217.
2. Diamant, M., Blaak, E., De Vos, W., Do nutrient–gut–microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?. Obes Rev 12 (2011), 272–281.
3. Clemente, J.C., Ursell, L.K., Parfrey, L.W., et al. The impact of the gut microbiota on human health: an integrative view. Cell 148 (2012), 1258–1270.
4. Robertson, M.D., Bickerton, A.S., Dennis, A.L., et al. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 82 (2005), 559–567.
5. Vrieze, A., Out, C., Fuentes, S., et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol 60 (2014), 824–831.
6. Vrieze, A., Van Nood, E., Holleman, F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (2012), 913–916.
7. Hulston, C.J., Churnside, A.A., Venables, M.C., Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects. Br J Nutr 113 (2015), 596–602.
8. Mikkelsen, K.H., Allin, K.H., Knop, F.K., Effect of antibiotics on gut microbiota, glucose metabolism and bodyweight regulation-a review of the literature. Diabetes Obes Metab 18 (2016), 444–453.
9. Kellow, N.J., Coughlan, M.T., Reid, C.M., Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. Br J Nutr 111 (2014), 1147–1161.
10. Ruan, Y., Sun, J., He, J., et al. Effect of probiotics on glycemic control: a systematic review and meta-analysis of randomized, controlled trials. PLoS One, 10, 2015, e0132121.
11. Roberfroid, M., Gibson, G.R., Hoyles, L., et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 104 (2010), S1–S63.
12. Delzenne, N.M., Neyrinck, A.M., Cani, P.D., Gut microbiota and metabolic disorders: how prebiotic can work?. Br J Nutr 109 (2013), S81–S85.
13. Vulevic, J., Juric, A., Tzortzis, G., et al. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 143 (2013), 324–331.
14. Vulevic, J., Drakoularakou, A., Yaqoob, P., et al. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 88 (2008), 1438–1446.
15. Canfora, E.E., Jocken, J.W., Blaak, E.E., Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11 (2015), 577–591.
16. van der Beek, C.M., Canfora, E.E., Lenaerts, K., et al. Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men. Clin Sci (Lond) 130 (2016), 2073–2082.
17. Maathuis, A.J., van den Heuvel, E.G., Schoterman, M.H., et al. Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a 13C-labeling technique. J Nutr 142 (2012), 1205–1212.
18. Holscher, H.D., Faust, K.L., Czerkies, L.A., et al. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. JPEN J Parenter Enteral Nutr 36 (2012), 95S–105S.
19. Davis, L.M., Martínez, I., Walter, J., et al. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One, 6, 2011, e25200.
20. Pokusaeva, K., Fitzgerald, G.F., van Sinderen, D., Carbohydrate metabolism in Bifidobacteria. Genes Nutr 6 (2011), 285–306.
21. Wendel-Vos, G.W., Schuit, A.J., Saris, W.H., et al. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 56 (2003), 1163–1169.
22. DeFronzo, R.A., Tobin, J.D., Andres, R., Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Gastrointest Liver Physiol 237 (1979), G214–G223.
23. Jaquet, D., Gaboriau, A., Czernichow, P., et al. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 85 (2000), 1401–1406.
24. Weir, J.B., New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109 (1949), 1–9.
25. Frayn, K.N., Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55 (1983), 628–634.
26. Orskov, C., Rabenhoj, L., Wettergren, A., et al. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43 (1994), 535–539.
27. García-Villalba, R., Giménez-Bastida, J.A., García-Conesa, M.T., et al. Alternative method for gas chromatography-mass spectrometry analysis of short-chain fatty acids in faecal samples. J Sep Sci 35 (2012), 1906–1913.
28. van Eijk, H.M., Bloemen, J.G., Dejong, C.H., Application of liquid chromatography–mass spectrometry to measure short chain fatty acids in blood. J Chromatogr B Analyt Technol Biomed Life 877 (2009), 719–724.
29. Salonen, A., Nikkilä, J., Jalanka-Tuovinen, J., et al. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods 81 (2010), 127–134.
30. Rajilić-Stojanović, M., Heilig, H.G., Molenaar, D., et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 11 (2009), 1736–1751.
31. Lahti, L., Elo, L.L., Aittokallio, T., et al. Probabilistic analysis of probe reliability in differential gene expression studies with short oligonucleotide arrays. IEEE/ACM Trans Comput Biol Bioinform 8 (2011), 217–225.
32. Bates, D., Maechler, M., Bolker, B., et al. Package ‘lme4’. Convergence, 12, 2015, 1.
33. Bates, D., Mächler, M., Bolker, B., et al. Fitting linear mixed-effects models using lme4. J Stat Software 67 (2015), 1–48.
34. Oksanen J, Blanchet FG, Kindt R, et al. Package ‘vegan’. Community ecology package, version 2, 2013.
35. Depeint, F., Tzortzis, G., Vulevic, J., et al. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr 87 (2008), 785–791.
36. Sierra, C., Bernal, M.-J., Blasco, J., et al. Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial. Eur J Nutr 54 (2015), 89–99.
37. Vulevic, J., Juric, A., Walton, G.E., et al. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Br J Nutr 114 (2015), 586–595.
38. Rossi, M., Corradini, C., Amaretti, A., et al. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl Environ Microbiol 71 (2005), 6150–6158.
39. Slavin, J., Fiber and prebiotics: mechanisms and health benefits. Nutrients 5 (2013), 1417–1435.
40. Boets, E., Gomand, S.V., Deroover, L., et al. Systemic availability and metabolism of colonic derived short chain fatty acids in healthy subjects: a stable isotope study. J Physiol 595 (2017), 541–555.
41. Walton, G.E., van den Heuvel, E.G., Kosters, M.H., et al. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Br J Nutr 107 (2012), 1466–1475.
42. Kaur, A., Rose, D.J., Rumpagaporn, P., et al. In vitro batch fecal fermentation comparison of gas and short-chain fatty acid production using “slowly fermentable” dietary fibers. J Food Sci 76 (2011), H137–H142.
43. Parnell, J.A., Reimer, R.A., Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89 (2009), 1751–1759.
44. Dewulf, E., Cani, P., Claus, S., et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62 (2013), 1112–1121.
45. O'Toole, P.W., Jeffery, I.B., Gut microbiota and aging. Science 350 (2015), 1214–1215.
46. Ley, R.E., Obesity and the human microbiome. Curr Opin Gastroenterol 26 (2010), 5–11.
47. Tremaroli, V., Bäckhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249.
48. Saraswati, S., Sitaraman, R., Aging and the human gut microbiota—from correlation to causality. Front Microbiol, 5, 2015, 764.
49. Ridaura, V.K., Faith, J.J., Rey, F.E., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
50. Khan, M.T., Nieuwdorp, M., Bäckhed, F., Microbial modulation of insulin sensitivity. Cell Metab 20 (2014), 753–760.
51. Walters, W.A., Xu, Z., Knight, R., Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett 588 (2014), 4223–4233.
52. Hermes, G., Zoetendal, E., Smidt, H., Molecular ecological tools to decipher the role of our microbial mass in obesity. Benef Microbes 6 (2014), 61–81.
53. Azcarate-Peril, M.A., Ritter, A.J., Savaiano, D., et al. Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. Proc Natl Acad Sci U S A 114 (2017), E367–E375.